# CNTB (Connect Biopharma Holdings Limited) - SEC EDGAR Financial Statements

> Connect Biopharma Holdings Limited reported $3.67M in revenue and a net loss of $67.94M for the trailing twelve months ended September 30, 2026 (up 4500.0% year over year), with a -1879.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/CNTB
- Markdown: https://convexityos.com/fundamentals/CNTB.md
- SEC CIK: 0001835268
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001835268&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $3.67M | +4500.0% YoY |
| Operating Income | TTM | -$69.05M | -1879.9% margin |
| Net Income | TTM | -$67.94M | -1849.7% net margin |
| Diluted EPS | TTM | -$1.08 | Split-adjusted |
| Free Cash Flow | TTM | -$55.25M | -1504.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $19.49M | Total debt: $496K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $64K | $26.03M | $0 | -- | -- |
| Research & Development | $37.80M | $29.26M | $53.00M | $96.63M | $80.50M |
| Total Operating Expenses | $58.14M | $48.48M | $69.06M | -- | -- |
| **Operating Income** | -$58.07M | -$22.45M | -$69.06M | -$119.3M | -$98.11M |
| **EBITDA** | -$57.37M | -$21.79M | -$68.34M | -$118.3M | -$97.47M |
| Interest Income | -- | -- | $2.71M | $1.54M | $97K |
| Interest Expense | -- | -- | $23K | $21K | $18K |
| Income Before Tax | -$55.28M | -$15.40M | -$61.99M | -$117.8M | -$202.0M |
| Income Tax Expense | $197K | $223K | $120K | $298K | $266K |
| **Net Income** | -$55.48M | -$15.63M | -$62.11M | -$118.1M | -$202.3M |
| Basic EPS | -$1.00 | -$0.28 | -$1.13 | -$2.15 | -$3.88 |
| **Diluted EPS** | -$1.00 | -$0.28 | -$1.13 | -$2.15 | -$3.88 |
| Basic Shares Outstanding | 55.7M | 55.2M | 55.1M | 55.0M | 52.2M |
| Diluted Shares Outstanding | 55.7M | 55.2M | 55.1M | 55.0M | 52.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $736K | $2.77M | $169K | $0 | $16K | $48K | $0 | -- |
| Research & Development | $12.79M | $16.27M | $15.03M | $11.28M | $11.11M | $8.77M | $6.63M | $6.24M |
| Total Operating Expenses | $17.05M | $20.37M | $19.78M | $15.53M | $17.69M | $13.47M | $11.45M | $10.32M |
| **Operating Income** | -$16.31M | -$17.60M | -$19.61M | -$15.53M | -$17.68M | -$13.42M | -$11.45M | -$9.62M |
| **EBITDA** | -$16.15M | -$17.44M | -$19.44M | -$15.35M | -$17.50M | -$13.25M | -$11.27M | -$9.46M |
| Income Before Tax | -$16.13M | -$17.22M | -$19.35M | -$15.08M | -$17.14M | -$12.84M | -$10.22M | -$8.80M |
| Income Tax Expense | $20K | $60K | $48K | $27K | $61K | $55K | $54K | $106K |
| **Net Income** | -$16.15M | -$17.28M | -$19.40M | -$15.11M | -$17.20M | -$12.90M | -$10.27M | -$8.91M |
| Basic EPS | -$0.26 | -$0.27 | -$0.34 | -- | -$0.31 | -$0.23 | -$0.19 | -- |
| **Diluted EPS** | -$0.26 | -$0.27 | -$0.34 | -- | -$0.31 | -$0.23 | -$0.19 | -- |
| Basic Shares Outstanding | 63.0M | 62.9M | 56.5M | -- | 55.7M | 55.5M | 55.4M | -- |
| Diluted Shares Outstanding | 63.0M | 62.9M | 56.5M | -- | 55.7M | 55.5M | 55.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $38.34M | $78.23M | $105.7M | $79.01M | $267.7M |
| Short-Term Investments | $6.00M | $15.48M | $12.64M | -- | -- |
| **Cash & Short-Term Investments** | $44.30M | $93.70M | $118.3M | $79.01M | $267.7M |
| Accounts Receivable, Net | $13K | $789K | $0 | -- | -- |
| Other Current Assets | -- | $53K | $54K | -- | -- |
| **Total Current Assets** | $50.93M | $96.96M | $122.6M | $155.8M | $275.1M |
| Property, Plant & Equipment, Net | $3.81M | $4.05M | $4.27M | $4.98M | $9.31M |
| Intangible Assets | $45K | $53K | $62K | -- | -- |
| Long-Term Investments | -- | -- | $0 | $0 | $0 |
| Other Non-Current Assets | $646K | $33K | $24K | $252K | $2.95M |
| **Total Non-Current Assets** | $5.15M | $4.32M | $4.92M | $18.23M | $15.93M |
| **Total Assets** | $56.08M | $101.3M | $127.4M | $174.0M | $291.1M |
| Accounts Payable | $1.96M | $342K | $2.21M | -- | -- |
| Deferred Revenue (Current) | $167K | $164K | $13.32M | $0 | $0 |
| **Total Current Liabilities** | $13.61M | $8.46M | $25.29M | $15.62M | $17.98M |
| Deferred Revenue (Non-Current) | -- | $632K | $405K | -- | -- |
| Other Non-Current Liabilities | $114K | $632K | -- | -- | -- |
| **Total Non-Current Liabilities** | $482K | $656K | $585K | $897K | $810K |
| **Total Liabilities** | $14.10M | $9.12M | $25.88M | $16.52M | $18.80M |
| **Total Debt (incl. Leases)** | $690K | $178K | $465K | $431K | $125K |
| Common Stock | $10K | $10K | $10K | $10K | $10K |
| Retained Earnings | -$400.8M | -$345.4M | -$329.7M | -$479.8M | -$361.8M |
| Accumulated Other Comp. Income | -$1.19M | -$1.67M | -$1.01M | -$7.63M | -$4.03M |
| **Total Stockholders' Equity** | $41.98M | $92.17M | $101.5M | $158.4M | $272.3M |
| Total Equity | $41.98M | $92.17M | $101.5M | $158.4M | $272.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.50M | $27.02M | $46.03M | $38.34M | $37.84M | $40.63M | $47.71M | $78.23M |
| Short-Term Investments | $2.99M | $4.47M | $0 | $6.00M | $16.94M | $31.14M | $36.29M | $15.48M |
| **Cash & Short-Term Investments** | $19.50M | $31.50M | $46.03M | $44.30M | $54.80M | $71.80M | $84.00M | $93.70M |
| Accounts Receivable, Net | $788K | $2.94M | $0 | $13K | $17K | $0 | $8.0K | $789K |
| Other Current Assets | -- | -- | -- | -- | -- | $228K | $65K | $53K |
| **Total Current Assets** | $23.14M | $38.62M | $55.02M | $50.93M | $62.60M | $77.76M | $87.75M | $96.96M |
| Property, Plant & Equipment, Net | $3.48M | $3.60M | $3.70M | $3.81M | $3.94M | $4.05M | $3.91M | $4.05M |
| Intangible Assets | $40K | $42K | $43K | $45K | $47K | $48K | $50K | $53K |
| Other Non-Current Assets | $646K | $646K | $646K | $646K | $45K | $45K | $45K | $33K |
| **Total Non-Current Assets** | $4.63M | $4.85M | $5.05M | $5.15M | $4.76M | $4.97M | $4.93M | $4.32M |
| **Total Assets** | $27.77M | $43.47M | $60.07M | $56.08M | $67.36M | $82.72M | $92.69M | $101.3M |
| Accounts Payable | $1.96M | $2.02M | $4.31M | $1.96M | $1.99M | $2.29M | $817K | $342K |
| Deferred Revenue (Current) | $0 | $0 | $0 | $167K | $165K | $164K | $164K | $164K |
| **Total Current Liabilities** | $15.49M | $16.30M | $17.05M | $13.61M | $11.43M | $10.74M | $8.56M | $8.46M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $632K |
| Other Non-Current Liabilities | $103K | $107K | $111K | $114K | $118K | $122K | $627K | $632K |
| **Total Non-Current Liabilities** | $220K | $310K | $398K | $482K | $563K | $642K | $1.22M | $656K |
| **Total Liabilities** | $15.71M | $16.61M | $17.44M | $14.10M | $11.99M | $11.38M | $9.79M | $9.12M |
| **Total Debt (incl. Leases)** | $496K | $596K | $693K | $690K | $781K | $870K | $940K | $178K |
| Common Stock | $11K | $11K | $11K | $10K | $10K | $10K | $10K | $10K |
| Retained Earnings | -$453.7M | -$437.5M | -$420.2M | -$400.8M | -$385.7M | -$368.5M | -$355.6M | -$345.4M |
| Accumulated Other Comp. Income | -$875K | -$962K | -$1.06M | -$1.19M | -$1.28M | -$1.38M | -$1.60M | -$1.67M |
| **Total Stockholders' Equity** | $12.05M | $26.86M | $42.62M | $41.98M | $55.37M | $71.34M | $82.90M | $92.17M |
| Total Equity | $12.05M | $26.86M | $42.62M | $41.98M | $55.37M | $71.34M | $82.90M | $92.17M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$55.48M | -$15.63M | -$62.11M | -$118.1M | -$202.3M |
| Depreciation & Amortization | $704K | $660K | $720K | $1.03M | $634K |
| Stock-Based Compensation | $3.73M | $6.73M | $5.40M | $6.91M | $8.99M |
| Change in Receivables | $776K | -$789K | $0 | -- | -- |
| Change in Payables | $1.62M | -$1.87M | -$1.14M | -$776K | $8.97M |
| **Operating Cash Flow** | -$51.21M | -$23.61M | -$47.74M | -$101.5M | -$84.32M |
| Capital Expenditure | -$434K | -$750K | -$81K | -$4.41M | -$3.83M |
| **Free Cash Flow** | -$51.64M | -$24.36M | -$47.82M | -$105.9M | -$88.16M |
| Purchases of Investments | -$30.47M | -$15.45M | -$31.03M | -- | -- |
| **Investing Cash Flow** | $9.82M | -$3.45M | $74.98M | -$86.24M | -$5.21M |
| Share Repurchases | -- | -- | $0 | $0 | -$566K |
| **Financing Cash Flow** | $1.09M | $227K | $45K | -$85K | $202.2M |
| **Net Change in Cash** | -$39.89M | -$27.43M | $26.72M | -$187.8M | $112.7M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$16.15M | -$17.28M | -$19.40M | -$15.11M | -$17.20M | -$12.90M | -$10.27M | -$8.91M |
| Depreciation & Amortization | $162K | $161K | $164K | $181K | $179K | $171K | $173K | $158K |
| Stock-Based Compensation | $1.26M | $1.26M | $1.20M | $917K | $916K | $951K | $942K | $1.40M |
| Change in Receivables | $2.15M | -$2.94M | $13K | $4.0K | -$17K | $8.0K | $781K | $4.23M |
| Change in Payables | -$55K | -$2.29M | $2.34M | -$30K | -$300K | $1.48M | $475K | -$41K |
| **Operating Cash Flow** | -$12.05M | -$15.92M | -$16.00M | -$11.25M | -$17.41M | -$12.59M | -$9.96M | -$2.32M |
| Capital Expenditure | -$6.0K | $0 | $0 | -$16K | -$34K | -$303K | -$81K | -$313K |
| **Free Cash Flow** | -$12.06M | -$15.92M | -$16.00M | -$11.27M | -$17.44M | -$12.89M | -$10.04M | -$2.63M |
| Purchases of Investments | $0 | -$4.47M | $0 | $0 | $0 | -$7.91M | -$22.56M | -$15.45M |
| **Investing Cash Flow** | $1.49M | -$4.47M | $6.00M | $10.98M | $14.35M | $5.13M | -$20.64M | -$15.76M |
| Common Stock Issued | $0 | $0 | $137K | -- | $215K | $18K | $2.0K | -- |
| **Financing Cash Flow** | $0 | $1.33M | $17.62M | $715K | $215K | $161K | $2.0K | $106K |
| **Net Change in Cash** | -$10.51M | -$19.02M | $7.69M | $500K | -$2.79M | -$7.08M | -$30.52M | -$18.96M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -90740.6% | -86.2% | -- | -- | -- |
| **Net Profit Margin** | -86687.5% | -60.0% | -- | -- | -- |
| Return on Equity (ROE) | -132.2% | -17.0% | -61.2% | -74.5% | -74.3% |
| Return on Assets (ROA) | -98.9% | -15.4% | -48.8% | -67.9% | -69.5% |
| Current Ratio | 3.74x | 11.46x | 4.85x | 9.97x | 15.30x |
| Quick Ratio | 3.26x | 11.17x | 4.68x | 5.06x | 14.89x |
| Debt to Equity | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -99.8% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1879.9% | -2384.5% | -28426.6% | -90740.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -1849.7% | -2336.3% | -27727.9% | -86687.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -563.6% | -256.8% | -151.6% | -132.2% | -89.0% | -63.0% | -20.8% | -17.0% |
| Return on Assets (ROA) | -244.7% | -158.7% | -107.6% | -98.9% | -73.2% | -54.3% | -18.6% | -15.4% |
| Current Ratio | 1.49x | 2.37x | 3.23x | 3.74x | 5.48x | 7.24x | 10.25x | 11.46x |
| Quick Ratio | 1.31x | 2.11x | 2.70x | 3.26x | 4.80x | 6.68x | 9.81x | 11.17x |
| Debt to Equity | 0.04x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x |
| **Revenue Growth (YoY)** | +4500.0% | +5666.7% | -- | -- | -98.7% | -99.8% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -198.4% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -186.9% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -185.2% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
